A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 2, 2011, Pages 153-158

  Guo, Lin ^a   Wu, Hanzhi ^a   Yue, Hao ^a   Lin, Shuhai ^a   Lai, Yongquan ^a   Cai, Zongwei ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Aristolochic acid; DNA adduct; Multiple reaction monitoring; Ultra performance liquid chromatography tandem mass spectrometry

Indexed keywords

ACCURACY AND PRECISION; ARISTOLOCHIC ACID; DETECTION LIMITS; DNA ADDUCT; DNA ADDUCTS; ENZYMATIC DIGESTIONS; FLUORESCENCE DETECTION; INTERNAL STANDARDS; MULTIPLE REACTION MONITORING; NEPHROPATHY; NON-INVASIVE; ORAL DOSE; POSITIVE ION MODE; RETENTION TIME; SOLID-PHASE EXTRACTION; TRIPLE-QUADRUPOLE MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPLC-MS/MS; URINE SAMPLE; UROTHELIAL CELLS;

CHROMATOGRAPHY; DNA; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; RATS;

EXTRACTION;

7 (DEOXYADENOSIN N6 YL)ARISTOLACTAM I; ARISTOLOCHIC ACID; PHOSPHORUS 32; PLANT MEDICINAL PRODUCT; RESERPINE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DNA ADDUCT; ELECTROSPRAY; KIDNEY CELL; KIDNEY DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY; TRIPLE QUADRUPOLE MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ANIMALS; ARISTOLOCHIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYADENOSINES; DNA ADDUCTS; LINEAR MODELS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINE; UROTHELIUM;

RATTUS;

EID: 78651225249     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.11.035     Document Type: Article

References (28)

1. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelenfastre R., Vanhaelen M. Lancet 1993, 341:387.
2. Vanherweghem J.L. J. Altern. Complement. Med. 1998, 4:9.
3. Vanhaelen M., Cuykens J.J., Vandenberg P.H., Bouman K.P., Hagens Y. Lancet 1998, 351:991.
4. Martinez M.C., Nortier J.L., Vereerstaeten P., Vanherweghem J.L. Nephrol. Dial. Transplant. 2002, 17:408.
5. Cosyns J.P. Drug Saf. 2003, 26:33.
6. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., De Pauw L., Abramowicz D., Vereerstraeten P., Vanherweghem J.L. N. Engl. J. Med. 2000, 342:1686.
7. Kumar V., Ponam D., Prasad A.K., Parmar V.S. Nat. Prod. Rep. 2003, 20:565.
8. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelić M., Jelaković B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12129.
9. Stiborova M., Frei E., Wiessler M., Schmeiser H.H. Chem. Res. Toxicol. 2001, 14:1128.
10. Stiborova M., Frei E., Sopko B., Wiessler M., Schmeiser H.H. Carcinogenesis 2002, 23:617.
11. Stiborova M., Frei E., Sopko B., Sopkova K., Markova V., Lankova M., Kumstyrova T., Wiessler M., Schmeiser H.H. Carcinogenesis 2003, 24:1695.
12. Krumbiegel G., Hallensleben J., Mennicke W.H., Rittmann N., Roth H.J. Xenobiotica 1987, 17:981.
13. Stiborová M., Frei E., Arlt V.M., Schmeiser H.H. Mutat. Res. 2008, 658:55.
14. Terashima I., Suzuki N., Shibutani S. Chem. Res. Toxicol. 2002, 15:305.
15. Stiborová M., Fernando R.C., Schmeiser H.H., Frei E., Pfau W., Wiessler M. Carcinogenesis 1994, 15:1187.
16. Dong H., Suzuki N., Torres M.C., Bonala R.R., Johnson F., Grollman A.P., Shibutani S. Drug Metab. Dispos. 2006, 34:1122.
17. Bieler C.A., Stiborova M., Wiessler M., Cosyns J.P., van Ypersele de Strihou C., Schmeiser H.H. Carcinogenesis 1997, 18:1063.
18. Chan W., Zheng Y.F., Cai Z.W. J. Am. Soc. Mass Spectrom. 2007, 18:642.
19. Chan W., Yue H., Poon W.T., Chan Y.W., Schmitz O.J., Kwong D.W.J., Wong R.N.S., Cai Z.W. Mutat. Res. 2008, 646:17.
20. Chan W., Cui L., Xu G.W., Cai Z.W. Rapid Commun. Mass Spectrom. 2006, 20:1755.
21. Chan W., Poon W.T., Chan Y.W., Wan K.Y., Cai Z.W. J. Chromatogr. B 2009, 877:848.
22. Schmeiser H.H., Janssen W., Lyons J., Scherf H.R., Pfau W., Buchmann A., Bartram C.R., Wiessler M. Cancer Res. 1990, 50:5464.
23. Arlt V.M., Wiessler M., Schmeiser H.H. Carcinogenesis 2000, 21:235.
24. Schmeiser H.H., Schoepe K.B., Wiessler M. Carcinogenesis 1988, 9:297.
25. Stiborova M., Frei E., Breuer A., Wiessler M., Schmeiser H.H. Mutat. Res. 2001, 493:149.
26. Talaska G., Dooley K.L., Kadlubar F.F. Carcinogenesis 1990, 11:639.
27. Pavlic M., Libiseller K., Oberacher H. Anal. Bioanal. Chem. 2006, 386:69.
28. Arlt V.M., Pfohl-Leszkowicz A., Cosyns J., Schmeiser H.H. Mutat. Res. 2001, 494:143.